Growth hormone: isoforms, clinical aspects and assays interference
Open Access
- 28 August 2018
- journal article
- review article
- Published by Springer Nature in Clinical Diabetes and Endocrinology
- Vol. 4 (1) , 18
Abstract
The measurement of circulating concentrations of growth hormone (GH) is an indispensable tool in the diagnosis of both GH deficiency and GH excess. GH is a heterogeneous protein composed of several molecular isoforms, but the physiological role of these different isoforms has not yet been fully understood. The 22KD GH (22 K-GH) is the main isoform in circulation, followed by 20KD GH (20 K-GH) and other rare isoforms. Studies have been performed to better understand the biological actions of the different isoforms as well as their importance in pathological conditions. Generally, the non-22 K- and 20 K-GH isoforms are secreted in parallel to 22 K-GH, and only very moderate changes in the ratio between isoforms have been described in some pituitary tumors or during exercise. Therefore, in a diagnostic approach, concentrations of 22 K-GH accurately reflect total GH secretion. On the other hand, the differential recognition of GH isoforms by different GH immunoassays used in clinical routine contributes to the known discrepancy in results from different GH assays. This makes the application of uniform decision limits problematic. Therefore, the worldwide efforts to standardize GH assays include the recommendation to use 22 K-GH specific GH assays calibrated against the pure 22 K-GH reference preparation 98/574. Adoption of this recommendation might lead to improvement in diagnosis and follow-up of pathological conditions, and facilitate the comparison of results from different laboratories.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 78 references indexed in Scilit:
- Postglucose growth hormone nadir and insulin-like growth factor-1 in naïve-active acromegalic patients: do these parameters always correlate?Archives of Endocrinology and Metabolism, 2011
- Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activitiesGrowth Hormone & IGF Research, 2010
- 20-kDa placental hGH-V has diminished diabetogenic and lactogenic activities compared with 22-kDa hGH-N while retaining antilipogenic activityAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- O‐Glycosylated 24 kDa human growth hormone has a mucin‐like biantennary disialylated tetrasaccharide attached at Thr‐60Proteomics, 2009
- Characterisation of the 5 kDa growth hormone isoformGrowth Factors, 2008
- Abuse of growth hormone by athletesNature Clinical Practice Endocrinology & Metabolism, 2007
- Nocturnal growth hormone secretory dynamics are altered after resistance exercise: deconvolution analysis of 12-hour immunofunctional and immunoreactive isoformsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Chronic resistance training in women potentiates growth hormone in vivo bioactivity: characterization of molecular mass variantsAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Serum Concentrations of 20K Human Growth Hormone in Normal Adults and Patients with Various Endocrine DisordersEndocrine Journal, 2000
- Antibodies to newly recognized murine 13–18 KDa pituitary peptides crossreact with growth hormone and prolactin from several species, including manBiochemical and Biophysical Research Communications, 1989